newsfilter
← Latest News
Business Wire·

Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy

– New collaboration builds on Sanofi's prior acquisition of DR-0201 and further leverages Dren Bio's proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class multispecific antibody